Cargando…

Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer

BACKGROUND: Chemokine (C-X-C motif) ligands (CXCLs) are important regulators of tumor progression in many cancers and could serve as potential cancer biomarkers. However, the expression patterns as well as functions of CXCLs remain unclear in penile cancer (PC). The aim of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Miao, Tong, Shiyu, Li, Tao, Zu, Xiongbing, Hu, Xiheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473990/ https://www.ncbi.nlm.nih.gov/pubmed/32943882 http://dx.doi.org/10.2147/OTT.S263980

Ejemplares similares

High serum CCL20 is associated with tumor progression in penile cancer
por: Mo, Miao, et al.
Publicado: (2020)

Serum CXCL5 level is associated with tumor progression in penile cancer
por: Mo, Miao, et al.
Publicado: (2021)

Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis
por: Cui, Can, et al.
Publicado: (2022)

RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer
por: Shi, Dazun, et al.
Publicado: (2022)

Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma
por: Mo, Miao, et al.
Publicado: (2021)

Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma
por: Li, Yangle, et al.
Publicado: (2021)

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
por: Xiao, Zicheng, et al.
Publicado: (2022)

The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer
por: Chen, Lujia, et al.
Publicado: (2015)

LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer
por: Li, Chao, et al.
Publicado: (2021)

Erratum to: The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer
por: Chen, Lujia, et al.
Publicado: (2016)

miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy
por: Long, Xingbo, et al.
Publicado: (2016)

P941: SERUM CXCL13 LEVEL AIDS IN DISEASE REMISSION EVALUATION AND PROGNOSIS PREDICTION IN WALDENSTRÖM MACROGLOBULINEMIA
por: Chen, Jia, et al.
Publicado: (2023)

Serum Level of Tumor-Overexpressed AGR2 Is Significantly Associated with Unfavorable Prognosis of Canine Malignant Mammary Tumors
por: Yuan, Stephen Hsien-Chi, et al.
Publicado: (2021)

CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer
por: Yu, Shengnan, et al.
Publicado: (2020)

Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
por: Li, Yangle, et al.
Publicado: (2019)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

A rapid unfavorable penile calciphylaxis case followed by total penectomy
por: Roquet‐Gravy, Charlotte, et al.
Publicado: (2021)

miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells
por: Lei, Ye, et al.
Publicado: (2015)

Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2021)

CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
por: Noto, Alessandra, et al.
Publicado: (2022)

Elevated serum levels of CXCL13 precede HIV-associated non-Hodgkin’s lymphoma
por: Hussain, Shehnaz K, et al.
Publicado: (2010)

Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren’s Syndrome
por: Chatzis, Loukas, et al.
Publicado: (2021)

TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma
por: Lu, Wang, et al.
Publicado: (2022)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy
por: Zhang, Mo, et al.
Publicado: (2019)

Unfavorable prognosis of nephroblastoma in adults
por: Huszno, Joanna, et al.
Publicado: (2013)

Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
por: Hsin, Li-Jen, et al.
Publicado: (2013)

Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma
por: Huang, Jiehao, et al.
Publicado: (2017)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018)

Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome
por: Traianos, Emmanuella Young, et al.
Publicado: (2020)

Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019)

Elevated RBP-Jκ and CXCL11 Expression in Colon Cancer is Associated with an Unfavorable Clinical Outcome
por: Liu, Meng-jie, et al.
Publicado: (2021)

HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2
por: Zhong, Xiaodan, et al.
Publicado: (2021)

MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMT
por: Zhao, Cheng, et al.
Publicado: (2020)

Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies
por: Hu, Jiao, et al.
Publicado: (2019)

Role of serum CXCL9 and CXCL13 in predicting infection after kidney transplant: A STROBE study
por: Yan, Lin, et al.
Publicado: (2021)

The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
por: Kim, Seok Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pl6jhetk1obqcio4cll9q8l11d